Acute Lymphoblastic Leukemia With Failed Remission Clinical Trials

10 clinical trials for Acute Lymphoblastic Leukemia With Failed Remission across international registries, including 5 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Determining the Mechanisms of Loss of CAR T Cell Persistence — RECRUITING
• MB-CART19.1 in Relapsed/Refractory Acute Lymphoblastic Leukemia — RECRUITING · NA
• Venetoclax Basket Trial for High Risk Hematologic Malignancies — RECRUITING · PHASE1
• Bortezomib-based Regimen for Refractory or Relapsed Acute Lymphoblastic Leukemia — RECRUITING · PHASE2
• CD19/CD22 CAR-T Cells in Adults With R/R ALL or NHL — RECRUITING · PHASE1
• CAR-T Cell Therapy Targeting to CD19 for R/R ALL — ACTIVE_NOT_RECRUITING · PHASE1
• Efficacy and Toxicity of Blinatumomab in the French ATU for Adult BCP-ALL R/R, or With MRD+ (FRENCH-CYTO) — COMPLETED
• CAR-20/19-T Cells in Patients With Relapsed/Refractory B Cell ALL — TERMINATED · PHASE1
• Safety and Feasibility of CD19 CAR T Cells Using CliniMACS Prodigy for Relapsed/Refractory CD19 Positive ALL and NHL — NOT_YET_RECRUITING · PHASE1
• Treatment With Combination Chemotherapy for Relapsed or Refractory Acute Lymphoblastic Leukemia — TERMINATED · PHASE1

Refine this search